NCT06524895 Reiki Breast Surgery QOL Project for Women Undergoing Breast Surgery
| NCT ID | NCT06524895 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Albert Einstein College of Medicine |
| Condition | Breast Cancer |
| Study Type | INTERVENTIONAL |
| Enrollment | 32 participants |
| Start Date | 2022-11-09 |
| Primary Completion | 2026-11 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 32 participants in total. It began in 2022-11-09 with a primary completion date of 2026-11.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This pilot study will examine the impact of pre-operative Medical Reiki© on the psychosocial well-being and recovery of underserved women undergoing breast cancer surgery.
Eligibility Criteria
Inclusion Criteria: * Ages 18-99 * Breast Cancer Diagnosis Stage 0-III * Undergoing unilateral or bilateral mastectomy (with or without reconstruction) within 2 weeks of recruitment * English Speaking * From within 50 miles of Bronx County, NY Exclusion Criteria: * Current, uncontrolled psychiatric co-morbidities * Pregnant women
Contact & Investigator
Alyson Moadel, PhD
PRINCIPAL INVESTIGATOR
Albert Einstein College of Medicine
Frequently Asked Questions
Who can join the NCT06524895 clinical trial?
This trial is open to female participants only, aged 18 Years or older, up to 99 Years, studying Breast Cancer. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06524895 currently recruiting?
Yes, NCT06524895 is actively recruiting participants. Contact the research team at Alyson.moadel-robblee@einsteinmed.edu for enrollment information.
Where is the NCT06524895 trial being conducted?
This trial is being conducted at The Bronx, United States.
Who is sponsoring the NCT06524895 clinical trial?
NCT06524895 is sponsored by Albert Einstein College of Medicine. The principal investigator is Alyson Moadel, PhD at Albert Einstein College of Medicine. The trial plans to enroll 32 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.